Viogen Labs Retatrutide 30mg Pen Kit

Viogen Labs Retatrutide 30mg is described in the supplied product information as a retatrutide formulation presented in a 3ml FlexiPen format. Retatrutide is an investigational compound being studied for its activity at GLP-1, GIP and glucagon receptors.

Product Overview

The source lists a total retatrutide content of 30mg and identifies the product as a solution intended for subcutaneous injection. Product identity, concentration, sterility and formulation details should be confirmed using reliable manufacturer documentation before this information is published as verified.

Product Specifications

• Brand: Viogen Labs
• Listed compound: Retatrutide
• Listed total content: 30mg
• Pen format: 3ml FlexiPen
• Storage information: 2–8°C, as stated in the supplied reference

Listed Excipients

The supplied product information lists the following excipients:

• Water for injection
• Sodium chloride
• Trehalose
• Disodium phosphate dihydrate
• Methionine
• M-Cresol
• Sodium hydroxide

These ingredients have been transcribed from the source and have not been independently verified for this product.

Important Information

Retatrutide remains an investigational medicine. Its safety, efficacy, appropriate dosage and long-term effects are still under study; it should not be represented as an established or approved weight-loss treatment.

The source's click-based measurement information has not been presented as a dosing recommendation. Do not rely on pen-click calculations or use an investigational product for self-treatment. Confirm regulatory status, authenticity, storage requirements and product documentation before publication or distribution.

This description is for general informational purposes and is not medical advice or a recommendation for human use.